🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 hora
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
02/12/1992 0,1193 USD
31/08/1992 0,1193 USD
02/06/1992 0,1097 USD
02/03/1992 0,1097 USD
02/12/1991 0,1002 USD
30/08/1991 0,1002 USD
03/06/1991 0,0891 USD
04/03/1991 0,0891 USD
03/12/1990 0,0891 USD
28/08/1990 0,0891 USD
29/05/1990 0,0716 USD
05/03/1990 0,0716 USD
04/12/1989 0,0716 USD
29/08/1989 0,0716 USD
30/05/1989 0,0652 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/03/1993 18,96 19,56 18,61 18,73 -1,88% 5,03% 6.347.526
10/03/1993 18,37 19,08 18,37 19,08 +4,92% 3,90% 8.220.093
09/03/1993 18,19 18,25 17,95 18,19 -0,33% 1,64% 4.635.514
08/03/1993 17,89 18,25 17,65 18,25 +2,00% 3,33% 5.692.946
05/03/1993 17,95 18,25 17,77 17,89 -0,66% 2,66% 5.094.118
04/03/1993 18,49 18,55 17,95 18,01 -2,27% 3,23% 4.461.126
03/03/1993 18,55 18,55 18,31 18,43 -0,64% 1,29% 3.933.144
02/03/1993 18,67 18,67 18,37 18,55 -1,58% 1,60% 4.900.867
01/03/1993 18,73 19,02 18,49 18,85 +2,60% 2,87% 5.949.077
26/02/1993 18,49 18,49 18,25 18,37 +0,33% 1,29% 3.678.690
25/02/1993 18,19 18,37 18,01 18,31 +0,00% 1,97% 6.002.315
24/02/1993 17,89 18,43 17,83 18,31 +1,99% 3,33% 8.125.563
23/02/1993 17,53 18,19 17,18 17,95 +2,73% 5,78% 9.666.752
22/02/1993 17,77 17,83 17,06 17,47 -0,68% 4,36% 10.278.574
19/02/1993 18,19 18,25 17,35 17,59 -2,64% 4,92% 9.538.896
18/02/1993 18,19 18,25 17,65 18,07 +1,00% 3,28% 8.871.320
17/02/1993 18,07 18,13 17,71 17,89 -0,99% 2,31% 9.614.981
16/02/1993 18,49 18,61 17,89 18,07 -6,19% 3,87% 11.239.171
12/02/1993 19,44 19,50 19,08 19,26 -0,92% 2,15% 5.256.768
11/02/1993 19,44 19,56 19,20 19,44 +1,24% 1,84% 6.283.389
10/02/1993 18,85 19,20 18,43 19,20 +2,88% 4,11% 7.193.682
09/02/1993 18,43 18,79 18,25 18,67 +1,62% 2,91% 6.062.470
08/02/1993 18,31 18,79 18,31 18,37 +0,33% 2,61% 6.376.451
05/02/1993 18,13 18,37 17,83 18,31 +0,99% 2,96% 7.417.534
04/02/1993 18,85 18,85 18,01 18,13 -2,88% 4,43% 8.388.402
03/02/1993 17,95 18,73 17,83 18,67 +3,99% 4,98% 12.918.277
02/02/1993 18,25 18,31 17,77 17,95 -3,22% 2,94% 16.541.422
01/02/1993 18,91 19,02 18,49 18,55 -3,72% 2,84% 8.968.784
29/01/1993 19,32 19,38 19,02 19,26 -0,31% 1,85% 4.455.258
28/01/1993 19,32 19,50 19,14 19,32 +0,62% 1,85% 5.395.104